The advent of high-throughput computational and RNA sequencing approaches in the past decade has highlighted an increasing number of RNA molecules in bacteria with critical functions in metabolic, physiological and virulence processes. Accordingly, proteins that interact with RNA have also benefited from a regained interest. A multitude of mechanisms involved in the regulation of gene expression by RNA molecules and in the interaction of RNAs with molecular partners have been described. There is a growing curiosity in understanding how RNA interferes or interacts with target DNA, RNA and proteins, and in the identification and characterization of nucleases, RNA helicases or RNA chaperones responsible for the activation, stability, decay or modes of action of RNA molecules. Remarkably, the recent analysis of CRISPR-Cas systems as RNA-mediated adaptive immune pathways in bacteria and archaea has resulted in the identification of novel families of proteins that function alone or in complexes to interact with RNA and/or DNA, and novel mechanisms of nucleic acid-based interference herewith. Information is now available on a large and still growing number of bacterial RNA molecules, the targets and functions of which are largely unknown. Given the enormous heterogeneity among different bacteria and the constant pressure for adaptation to multiple stresses and environments, we expect to discover a wide variety of novel RNAs with regulatory functions and associated proteins. We predict exciting findings and innovation in the field of RNA research in bacteria for a number of years to come.

In this issue, *FEMS Microbiology Reviews* has selected a series of articles that highlight some of the recent findings on RNA biology in bacteria focusing on RNA biogenesis, modes of action, regulatory mechanisms and functions. The continuous effort to adapt innovative technologies and biological approaches to the bacterial RNA field has advanced our understanding of how regulatory RNAs and their interacting partners function and cooperate in the cell to fine-tune gene expression in response to changing environmental conditions and stresses and thereby affect the physiology of bacteria at multiple levels. The reviews provide detailed overviews on tRNAs, selected regulatory small RNAs and 5^′^ UTR elements, as well as RNAs from toxin--antitoxin (TA) systems. The biology, biochemistry, targets and roles of some of these RNAs in bacterial physiology from metabolism to adaptation and virulence are described. This issue on bacterial RNA biology also surveys mechanisms evolved by protein co-factors such as RNases and RNA helicases to assist in the RNA biogenesis, turnover and/or modes of interaction of RNAs with their targets or partners. Finally, the issue highlights the most recent findings on the mechanisms of biogenesis of the guide CRISPR RNAs (crRNAs) and their interference with DNA or RNA of invading genomes.

The review by Shepherd and Ibba on 'Bacterial transfer RNAs**'** provides a comprehensive overview of the current knowledge on tRNA biology, featuring insights into the most significant aspects of transcription, maturation, aminoacylation and non-canonical roles of tRNAs in bacteria. Although many of these biological processes have been extensively investigated for decades, Shepherd and Ibba have compiled early studies with the most recent findings in a chronological order. Moreover, this review highlights the trending topics and advancements in the tRNA field, which go far beyond the translation of the genetic code.

Three reviews focus specifically on the small RNAs and interacting proteins in particular groups of bacteria. These are the articles on 'Regulatory RNAs in photosynthetic cyanobacteria**'** by Kopf and Hess, on 'sRNA and mRNA turnover in Gram-positive bacteria**'** by Durand *et al.* and on the 'Small RNAs, 5^′^ UTR elements and RNA-binding proteins in intracellular bacteria: impact on metabolism and virulence**'** by Oliva *et al.*

The review by Kopf and Hess on 'Regulatory RNAs in photosynthetic cyanobacteria**'** focusses on recently described cases of sRNAs in various different cyanobacteria, but the bulk of reviewed work is from *Synechocystis* sp. PCC 6803, the work horse of cyanobacteriology. Cyanobacteria are the only prokaryotes that perform oxygenic photosynthesis and therefore the recent discovery of PsrR1, an sRNA that controls multiple proteins of the photosynthetic apparatus, is of high interest. In this article, special attention is paid to new concepts that are based on recent findings in photosynthetic cyanobacteria. These include transcripts that initially were thought to be non-coding but on closer inspection turned out to contain μORFs and encode short proteins that can be functionally important. Another novelty suggested on the basis of transcriptome analyses in cyanobacteria are actuatons, a new class of genetic elements in which an sRNA gene is inserted upstream of a coding region to modify or enable transcription of that region. For the reader interested in further detail, the review is linked to two datasets that provide the sequences of 33 abundant sRNAs in two closely related *Synechocystis* strains.

The specificities in the mRNA degradation machinery and in the mode of action of regulatory RNAs in Gram-positive bacteria are highlighted by Durand *et al.* in their review on 'sRNA and mRNA biogenesis and turnover in Gram-positive bacteria**'**. These processes now have been characterized to a level comparable to Gram-negative bacteria. The authors do not review the complete list of sRNAs in these bacteria but rather focus on specific cases where links between sRNAs and the degradation machinery have been unraveled. The review mainly summarizes results from the low G-C content Gram-positive *Bacillus subtilis*, *Staphylococcus aureus* and *Streptococcus pyogenes*, but intersects with data obtained from other Gram-positive bacteria, such as the high G-C content Actinobacteria *Mycobacterium tuberculosis* and *M. smegmatis*, which encode a mixture of RNases from enterobacteria as well as Gram-positive bacteria. Obviously, RNases are the key enzymes in sRNA and mRNA turnover, and therefore Durand *et al.* present the existing knowledge on these proteins in a comprehensive way. Among the covered enzymes are RNAse Y, the RNases J1 and J2, the double-strand specific endoribonuclease RNase III, but also PNPase, which is a very important player in mRNA degradation in *B. subtilis.* Moreover, the mechanisms of three more 3^′^-5^′^ exoribonucleases, known from *B. subtilis*, are covered. One, the RNase PH, is acting by phosphorolysis similar to PNPase, whereas the other two are hydrolytic enzymes, named RNase R and YhaM. All three exoribonucleases could help to degrade mRNA.

The review by Oliva *et al.* 'Small RNAs, 5^′^ UTR elements and RNA-binding proteins in intracellular bacteria: impact on metabolism and virulence**'** emphasizes the roles and modes of action of sRNAs and 5^′^ UTR elements of bacteria such as *Chlamydia trachomatis, Salmonella enteric*a serovars, or *Neisseria*, *Legionella*, *Listeria*, *Brucella* and *Mycobacterium* species. The article pays particular attention on those sRNAs and *cis*-encoded antisense RNAs that are expressed during replication in the invaded host cells and are involved in virulence and metabolism. These sRNAs include *trans*-encoded sRNAs that are responding to iron levels in the host cell and that are shared among multiple bacterial pathogens, possibly because they are part of similar strategies to respond to iron and/or oxidative stress within the host cells. In all bacteria, RNA-binding proteins play an essential role in the regulatory networks. The article reviews one of the best studied of such networks, the CsrA/RsmA (carbon storage regulator/regulator of secondary metabolism) ribonucleoprotein complex, which in pathogenic bacteria controls different metabolic pathways and the repression of a variety of stationary-phase genes, including virulence-linked traits. Among the discussed 5^′^ UTR elements are riboswitches and RNA thermometers, elements, which in some bacteria contribute to virulence, immune evasion and resistance to complement increase in a remarkable way.

As mentioned above, RNases play a central role in RNA metabolism. Because of their ability to act as destructive enzymes, RNases need to be tightly regulated to prevent the indiscriminate degradation of functionally critical RNA molecules that could be detrimental to the bacterial cells. Deutscher in his article 'How bacterial cells keep ribonucleases under control' describes how cells have evolved a variety of strategies to protect RNAs from undesirable RNase actions and regulate the RNases to limit their activity. The review particularly focuses on our current understanding of the mechanisms involved in RNase regulation that has received little attention compared to RNA protection processes. Deutscher gives details on transcriptional, translational and post-translational processes, specific mechanisms evolved by the RNases and factors that modulate the enzymatic activities of specific and individual RNases.

A recurrent mode of action of bacterial sRNAs is repression of gene expression by basepairing to target mRNAs. Recent examples in the literature show however that sRNAs can also activate gene expression. The review by Papenfort and Vanderpool, 'Target activation by regulatory RNAs in bacteria', discusses recent advances in our understanding of the translation activation and mRNA stabilization mechanisms involved in sRNA-mediated positive gene regulation. Details of targeted sequences and base-pairing mechanisms are provided, showing that the mechanisms governing activation differ substantially from those that result in repression. The roles of cellular RNases and the RNA chaperone Hfq, and the physiological conditions associated to post-transcriptional target activation are further described. The authors provide also their perspectives on alternative mechanisms of sRNA-mediated positive gene regulation using base pairing with other sRNAs or titration of RNA-interacting proteins.

In their review 'How do base pairing small RNAs evolve?', Updegrove *et al.* focus on the requirements and evolutionary conservation in the base pairings between bacterial *trans*-encoded sRNAs and their target mRNAs. First, the authors discuss the benefit of regulation by sRNAs in concert to simultaneous regulation by transcription factors. Possible mechanisms of sRNA evolution with respect to selective pressure on the sRNAs and their targets are discussed. The sRNA-target mRNA evolution is also examined in the context of both physiological and mechanistical constraints. A perspective is given on the evolutionary aspects of bacterial sRNAs and eukaryotic regulatory RNAs (miRNAs and siRNAs) at the level of their base pairings with target mRNAs, the secondary structures of sRNAs and accessibility of target mRNAs, and the ability of the sRNAs to target multiple target mRNAs.

Almost all regulatory RNAs do not work by themselves alone but in concert with different kinds of protein co-factors. The very important role that RNA helicases play in these processes is reviewed by Redder *et al.* in the article **'**Bacterial versatility requires DEAD-box RNA helicases**'.** DEAD-box helicases are biochemically versatile. They have the power to modify RNA secondary structures or intermolecular RNA interactions by RNA unwinding, RNA annealing, RNA clamping, as well as to modulate RNA--protein complexes by displacing protein from RNA, and can play a role in metabolite sensing. Therefore, it is no surprise that they are almost ubiquitous in bacteria and even occur in small gene families in some genomes, exemplified by *Shewanella baltica* encoding 12 of these proteins, whereas *Escherichia coli* and *B. subtilis* encode five and four RNA helicases, respectively. RNA helicases are missing in some intracellular bacteria, but for others it is not obvious why they do not possess DEAD-box proteins.

It has only recently been recognized that there are virtually no bacteria without TA systems. These systems are small genetic elements composed of a stable toxic protein and its unstable cognate antitoxin. TA systems are categorized into five different types and from these, two use a regulatory RNA molecule as the antitoxin. These are reviewed by Brantl and Jahn in their article 'sRNAs in bacterial type I and type III toxin-antitoxin systems**'.** There is substantial information on structural requirements, kinetics of interaction with their targets and regulatory mechanisms of selected antitoxin RNAs, mainly of plasmid-located systems. The authors summarize this knowledge and discuss biological roles for chromosome-encoded TA systems, which have been much less well investigated until the current day.

About 50% of bacteria whose complete genome has so far been analyzed encode RNA-mediated CRISPR-Cas adaptive immune systems. These systems provide bacteria with protection against mobile genetic elements such as phages and plasmids. A common theme in the CRISPR-Cas immune pathway is the formation of ribonucleoprotein complexes that consist of the association between the CRISPR RNAs (crRNAs) functioning as guides and the CRISPR-associated (Cas) protein(s). The systems have highly evolved and various distinct highly sophisticated mechanisms are used for the recognition of the invading genomes during the adaptive phase of the pathway, and expression and maturation of the guide crRNAs and targeting of the invading nucleid acid by the crRNA-Cas ribonucleoprotein complexes during the interference phase. Charpentier *et al.* in their article 'Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity' describe the details of the mechanisms involved in the formation of the mature guide crRNAs containing the signature of the invading genomes. Originally, the CRISPR-Cas system was referred to as the prokaryotic RNA interference system in analogy to the eukaryotic RNA interference pathways that target mRNA using small interfering RNAs or microRNAs as guides. Recent findings have shown that most of the CRISPR-Cas systems target DNA with only one example of a CRISPR-Cas type that targets RNA. Plagens *et al.* in their article 'DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes' present a detailed overview of the mechanisms of recognition of target nucleic acids during the step of interference. In both reviews, structural details of the processing, surveillance and interfering complexes involved are provided and mechanistic themes shared among or distinguishing the type I, type II (CRISPR-Cas9) and type III CRISPR-Cas systems are discussed.
